Total Payments
$3,016
2024 Payments
$79.67
Companies
37
Transactions
167
Medicare Patients
7,935
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$2,995 (99.3%)
Education$21.47 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,995 | 166 | 99.3% |
| Education | $21.47 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $312.65 | 12 | $0 (2021) |
| Abbott Laboratories | $266.55 | 10 | $0 (2022) |
| Orthogenrx Inc. | $192.79 | 7 | $0 (2019) |
| Purdue Pharma L.P. | $181.85 | 16 | $0 (2018) |
| Fidia Pharma USA Inc. | $146.49 | 7 | $0 (2023) |
| Allergan, Inc. | $145.35 | 8 | $0 (2020) |
| Collegium Pharmaceutical, Inc. | $134.60 | 9 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $132.42 | 9 | $0 (2020) |
| Arteriocyte Medical Systems, Inc. | $123.84 | 2 | $0 (2019) |
| Ferring Pharmaceuticals Inc. | $120.74 | 9 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $79.67 | 4 | Avanos Medical ($41.60) |
| 2023 | $144.18 | 6 | Collegium Pharmaceutical, Inc. ($36.49) |
| 2022 | $88.30 | 4 | ABBVIE INC. ($26.35) |
| 2021 | $72.92 | 5 | BioDelivery Sciences International, Inc. ($53.60) |
| 2020 | $93.86 | 6 | Ferring Pharmaceuticals Inc. ($31.58) |
| 2019 | $744.85 | 30 | Amgen Inc. ($232.81) |
| 2018 | $857.22 | 47 | Orthogenrx Inc. ($173.55) |
| 2017 | $935.23 | 65 | Purdue Pharma L.P. ($156.51) |
All Payment Transactions
167 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/24/2024 | Avanos Medical | TRIVISC SODIUM HYALURONATE (Device) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/31/2024 | DePuy Synthes Sales Inc. | MONOVISC (Device), ORTHOVISC | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Sports Early Intervention | ||||||
| 04/15/2024 | Otto Bock HealthCare LP | — | Education | Cash or cash equivalent | $21.47 | General |
| 03/18/2024 | Avanos Medical | GENVISC 850 SODIUM HYALURONATE (Device) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/07/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.23 | General |
| Category: Opioid Analgesic | ||||||
| 11/01/2023 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $27.45 | General |
| Category: Pain management | ||||||
| 10/24/2023 | Fidia Pharma USA Inc. | HYMOVIS (Device) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: OSTEOARTHRITIS | ||||||
| 08/29/2023 | Avanos Medical | TRIVISC SODIUM HYALURONATE (Device) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/17/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $20.26 | General |
| Category: Opioid Analgesic | ||||||
| 01/19/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $32.88 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/28/2022 | Fidia Pharma USA Inc. | HYMOVIS (Device), TRILURON | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: OSTEOARTHRITIS | ||||||
| 07/20/2022 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.06 | General |
| Category: Opioid Analgesic | ||||||
| 06/03/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Neuromodulation | ||||||
| 04/06/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: HYPERHYDROSIS | ||||||
| 10/25/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: Chronic Pain | ||||||
| 10/05/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Chronic Pain | ||||||
| 08/14/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Chronic Pain | ||||||
| 06/15/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: Chronic Pain | ||||||
| 05/07/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Neuroscience | ||||||
| 03/25/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/11/2020 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: ORTHOPEDICS | ||||||
| 03/09/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: HYPERHYDROSIS | ||||||
| 02/12/2020 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: ORTHOPEDICS | ||||||
| 01/24/2020 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Neuroscience | ||||||
| 01/13/2020 | BIODELIVERY SCIENCES INTERNATIONAL, INC. | BUNAVAIL (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Addiction Therapy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,913 | 5,549 | $1.1M | $219,829 |
| 2022 | 25 | 2,243 | 7,518 | $1.3M | $289,074 |
| 2021 | 26 | 1,806 | 5,739 | $1.1M | $275,344 |
| 2020 | 27 | 1,973 | 7,057 | $1.2M | $292,537 |
Total Patients
7,935
Total Services
25,863
Medicare Billing
$1.1M
Procedure Codes
108
All Medicare Procedures & Services
108 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 380 | 816 | $122,400 | $72,910 | 59.6% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 174 | 255 | $182,975 | $23,251 | 12.7% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 113 | 197 | $78,300 | $17,413 | 22.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 184 | 272 | $27,200 | $17,273 | 63.5% |
| J7322 | Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | Office | 2023 | 20 | 1,272 | $184,440 | $16,621 | 9.0% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 45 | 75 | $59,100 | $11,042 | 18.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 86 | 86 | $19,780 | $9,506 | 48.1% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 28 | 41 | $32,800 | $5,931 | 18.1% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 115 | 156 | $62,400 | $5,665 | 9.1% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 39 | 62 | $37,715 | $5,551 | 14.7% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2023 | 29 | 49 | $29,610 | $5,006 | 16.9% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 58 | 65 | $26,845 | $4,615 | 17.2% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 38 | 50 | $24,700 | $3,688 | 14.9% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 200 | 396 | $84,348 | $3,529 | 4.2% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 45 | 75 | $35,828 | $3,400 | 9.5% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 39 | 61 | $23,126 | $3,166 | 13.7% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Facility | 2023 | 28 | 48 | $19,113 | $2,802 | 14.7% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 28 | 41 | $21,375 | $2,105 | 9.8% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 25 | 29 | $17,316 | $1,972 | 11.4% |
| 64479 | Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | Facility | 2023 | 11 | 11 | $6,600 | $1,001 | 15.2% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 18 | 20 | $5,260 | $878.53 | 16.7% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 18 | 18 | $2,592 | $694.44 | 26.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2023 | 16 | 17 | $3,432 | $642.21 | 18.7% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 12 | 12 | $2,556 | $462.12 | 18.1% |
| 77002 | Fluoroscopic guidance for needle placement | Facility | 2023 | 16 | 17 | $1,527 | $334.08 | 21.9% |
About Dr. Michael Wolff, M.D
Dr. Michael Wolff, M.D is a Pain Medicine healthcare provider based in Scottsdale, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376508697.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Wolff, M.D has received a total of $3,016 in payments from pharmaceutical and medical device companies, with $79.67 received in 2024. These payments were reported across 167 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($2,995).
As a Medicare-enrolled provider, Wolff has provided services to 7,935 Medicare beneficiaries, totaling 25,863 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 108 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Location Scottsdale, AZ
- Active Since 04/19/2006
- Last Updated 12/15/2008
- Taxonomy Code 2081P2900X
- Entity Type Individual
- NPI Number 1376508697
Products in Payments
- Aimovig (Biological) $287.77
- GenVisc 850 (Device) $192.79
- Proclaim Family of SCS IPGs (Device) $179.29
- EUFLEXXA (Device) $120.74
- RELISTOR ORAL (Drug) $119.33
- Nucynta (Drug) $111.16
- OXYCONTIN (Drug) $100.03
- XTAMPZA (Drug) $95.17
- Senza Spinal Cord Stimulation System (Device) $86.18
- RELISTOR (Drug) $73.95
- Hymovis (Device) $73.65
- BOTOX THERAPEUTIC (Biological) $67.88
- Morphabond ER (Drug) $65.89
- BOTOX (Biological) $59.15
- LYRICA (Drug) $54.69
- GELSYN 3 (Device) $54.25
- SYNVISC-ONE (Device) $53.97
- BELBUCA (Drug) $53.60
- GENERATOR (Device) $50.68
- ENTRADA (Device) $49.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Scottsdale
Dr. Tory Mcjunkin, M.d, M.D
Pain Medicine — Payments: $293,715
Pain Medicine $293,715
Vivek Iyer, M.d, M.D
Pain Medicine — Payments: $70,453
Pain Medicine $70,453
Dr. Nikesh Seth, Md, MD
Pain Medicine — Payments: $63,910
Pain Medicine $63,910
Dr. Steve Fanto, Md, MD
Pain Medicine — Payments: $43,057
Pain Medicine $43,057
Dr. Matthew Crooks, Md, MD
Pain Medicine — Payments: $20,391
Pain Medicine $20,391
Natalie Strand, M.d, M.D
Pain Medicine — Payments: $19,142
Pain Medicine $19,142